← All trials
NCT05182749
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2022
- Primary completion
- Apr 30, 2025
- Completion date
- Apr 30, 2025
- First posted
- Jan 10, 2022
- Last posted
- Jun 22, 2022
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Intralytix, Inc.Lead sponsor
- University of MarylandCollaborator
- University of MarylandOverall official - principal investigator
- Intralytix, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.